Capsule Magnesium
- All
- News
-
Aurobindo Pharma Gets US Regulator's Nod for Gastro Reflux Drug
- Friday April 22, 2016
- Business | Press Trust of India
Drug firm Aurobindo Pharma has received final approval from US Food and Drug Administration (FDA) to manufacture and market Esomeprazole Magnesium delayed release capsules, used in treatment of gastro-esophageal reflux disease, in the American market.
-
www.ndtv.com/business
-
Dr Reddy's Relaunches Generic Drug in US
- Wednesday December 30, 2015
- Business | Press Trust of India
Dr Reddy's Laboratories has relaunched its generic Esomeprazole Magnesium capsules used for treatment of acid reflux, in the US market.
-
www.ndtv.com/business
-
Dr Reddy's Lab Surges 6% on New Drug Launch
- Monday September 28, 2015
- Business | NDTV
Surjit Pal, pharma analyst at Prabhudas Lilladher, said with the launch of the generic version of Nexium, Dr. Reddy's will be able to capture 10-12 per cent of market share in one year, which may add approximately Rs 12 to its annual earnings per share.
-
www.ndtv.com/business
-
Aurobindo Pharma Gets US Regulator's Nod for Gastro Reflux Drug
- Friday April 22, 2016
- Business | Press Trust of India
Drug firm Aurobindo Pharma has received final approval from US Food and Drug Administration (FDA) to manufacture and market Esomeprazole Magnesium delayed release capsules, used in treatment of gastro-esophageal reflux disease, in the American market.
-
www.ndtv.com/business
-
Dr Reddy's Relaunches Generic Drug in US
- Wednesday December 30, 2015
- Business | Press Trust of India
Dr Reddy's Laboratories has relaunched its generic Esomeprazole Magnesium capsules used for treatment of acid reflux, in the US market.
-
www.ndtv.com/business
-
Dr Reddy's Lab Surges 6% on New Drug Launch
- Monday September 28, 2015
- Business | NDTV
Surjit Pal, pharma analyst at Prabhudas Lilladher, said with the launch of the generic version of Nexium, Dr. Reddy's will be able to capture 10-12 per cent of market share in one year, which may add approximately Rs 12 to its annual earnings per share.
-
www.ndtv.com/business